Community Connect: Code to Cure highlighted how AI is transforming life sciences today—accelerating discovery, reshaping patient care, and opening early opportunities for those ready to lead the next wave of innovation.
“We are in the AOL days of AI… That’s how early we are in this transformational phase… The things that are happening in biosciences and things that are to come, there’s so much opportunity to take advantage of right now.”
– Jason Michael Perry, PerryLabs
This insight set the tone for the fifth edition of Community Connect: Code to Cure at Montgomery College’s Pinkney Innovation Complex for Science and Technology (PIC MC). The event brought together some of the region’s brightest minds to explore how AI is reshaping life sciences, from research and infrastructure to patient impact.
AI and the Life Sciences Revolution
AI is transforming industries across the board, but the most striking innovations are emerging in biotechnology and healthcare. From streamlining data analysis to optimizing lab workflows, AI is breaking down inefficiencies and accelerating discovery.
For example, Netrias founder Dr. Mohammed Eslami demonstrated AI-driven data curation, transforming raw biological datasets into fully structured, harmonized formats–enabling faster discovery and clinical translation.
Dr. Sherry Dadgar, CEO and Laboratory Director at Personalized Medicine Care Diagnostics (PMCDx), highlighted how AI shortens genomic analysis timelines. “The average time that human beings take to analyze the whole exome is 10 to 16 hours, and for the whole genome can take up to 25 hours. Now AI can do all of these processes faster than that,” she explained, demonstrating AI’s potential to transform diagnostics and patient care.
Collective Effort: From Students to Researchers
Realizing AI’s potential in life sciences is a collective effort–from early education to cutting-edge research–creating a long-term pipeline of trained researchers.
This philosophy was evident during the STEM Academy demo led by Dr. Jude Abanulo, which showcased hands-on robotics and coding programs for students. Activities ranged from graphical coding and maze navigation to tactile feedback and Python-based programming, cultivating creativity, confidence, and real-world STEM skills.
Why Timing Matters
Perry framed the current moment in AI as the beginning of a revolution comparable to the early days of personal computing, the Internet, and mobile technology:
“The companies today, the five most valuable companies today, are all tied to those revolutions. It starts with Nvidia, now worth almost $4 trillion, right? You have Microsoft, Apple, Google. Right? Isn’t that crazy to think that over the last few years, the most value was generated by these revolutions? … Everyone believes that AI is going to be more of a transformation, bigger transformation, than any of those transformations ever before. That says just how important this period is.”
Perry’s perspective highlights not just the technological promise of AI but also the immense economic and societal impact it is expected to generate. Like the internet & other emerging technologies, AI is already reshaping industries. In life sciences, that means accelerating drug discovery, personalizing treatment plans, reducing the cost of clinical trials, and even transforming how biomanufacturing facilities operate. For researchers, companies, and policymakers alike, the key message is clear: engaging early in this revolution will determine who leads the next era of innovation.
Looking Ahead
Whether attendees came for the demos, dialogue, or networking, the message was clear: AI in life sciences is still in its infancy, and those who engage now will help shape its future. Community Connect: Code to Cure showed how far the field has come, and how much potential lies ahead.
Interested in continuing the conversation & learning about another emerging topic? Join us for the next Community Connect event on BioDefense, taking place October 1. Register here.
